Caribou Biosciences (CRBU) Research & Development (2020 - 2026)

Caribou Biosciences (CRBU) has 7 years of Research & Development data on file, last reported at $20.6 million in Q1 2026.

• On a quarterly basis, Research & Development fell 41.99% year-over-year to $20.6 million in Q1 2026; TTM through Mar 2026 was $94.5 million, a 28.34% decrease from a year earlier, with the FY2025 full-year figure at $109.4 million, down 15.92% from the prior year.
• Research & Development for Q1 2026 stood at $20.6 million, down from $23.8 million in the prior quarter.
• Over the last five years, Research & Development for CRBU reached as high as $35.5 million in Q1 2025 and fell as low as $13.9 million in Q1 2022.
• Historically, Research & Development has averaged $26.7 million across 5 years, with a median of $26.5 million in 2023.
• Across the five-year window, Research & Development soared 84.64% in 2023 and slumped 41.99% in 2026, its largest moves.
• Year by year, Research & Development stood at $25.7 million in 2022, then advanced by 21.54% to $31.3 million in 2023, then slipped by 2.61% to $30.5 million in 2024, then fell by 21.83% to $23.8 million in 2025, then dropped by 13.45% to $20.6 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $20.6 million in Q1 2026, $23.8 million in Q4 2025, and $22.4 million in Q3 2025.